The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 05, 2019

Filed:

Dec. 25, 2014
Applicant:

Japan Science and Technology Agency, Kawaguchi-shi, Saitama, JP;

Inventors:

Kazuo Sakurai, Kitakyushu, JP;

Shin-ichi Mochizuki, Kitakyushu, JP;

Hiromi Morishita, Kitakyushu, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 47/64 (2017.01); A61K 39/39 (2006.01); A61K 39/29 (2006.01); A61K 39/15 (2006.01); A61K 39/13 (2006.01); A61K 39/00 (2006.01); A61K 39/385 (2006.01); A61K 31/7088 (2006.01); C07K 14/77 (2006.01); C07K 19/00 (2006.01); A61K 39/015 (2006.01); A61K 39/145 (2006.01); A61K 39/205 (2006.01); A61K 39/245 (2006.01); C12N 15/117 (2010.01);
U.S. Cl.
CPC ...
A61K 39/385 (2013.01); A61K 31/7088 (2013.01); A61K 39/0011 (2013.01); A61K 39/015 (2013.01); A61K 39/13 (2013.01); A61K 39/145 (2013.01); A61K 39/15 (2013.01); A61K 39/205 (2013.01); A61K 39/245 (2013.01); A61K 39/292 (2013.01); A61K 39/39 (2013.01); A61K 47/646 (2017.08); C07K 14/77 (2013.01); C07K 19/00 (2013.01); C12N 7/00 (2013.01); C12N 15/117 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/572 (2013.01); A61K 2039/6025 (2013.01); A61K 2039/6081 (2013.01); A61K 2039/6087 (2013.01); C12N 2310/17 (2013.01); C12N 2320/31 (2013.01); C12N 2710/16634 (2013.01); C12N 2730/10134 (2013.01); C12N 2740/16034 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/18034 (2013.01); C12N 2770/32634 (2013.01);
Abstract

This peptide/β-1,3-glucan complex includes β-1,3-glucan and a peptide/polynucleotide conjugate in which an antigenic peptide is bonded covalently to a polynucleotide or a derivative thereof. The polynucleotide or derivative thereof of the peptide/polynucleotide conjugate bonds via a hydrogen bond with β-1,3-glucan, forming a complex having a triple helix structure including a single molecular chain of the polynucleotide or derivative thereof and two molecular chains of the β-1,3-glucan. Alternatively, the side chain of the β-1,3-glucan and the antigenic peptide are bonded covalently formed by either a cycloaddition reaction between an alkyne and an azide derivative, or a reaction between a maleimide group or a vinyl sulfone group and a thiol group.


Find Patent Forward Citations

Loading…